AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
eMed raises $200M in Series A led by Tom Brady and prominent investors, valuation exceeds $2B. The AI healthcare startup plans to expand digital wellness access.
eMed, a Miami-based digital healthcare company, has closed a $200 million Series A funding round, valuing the startup above $2 billion. Tom Brady, serving as the company's founding chief wellness officer, led the investment alongside prominent investors including Linda Yaccarino (former X CEO), AON Consulting, Paragon Biosciences founder Jeff Aronin, and Valor Equity Partners CEO Antonio Gracias. Additional investors include 8VC founder Joe Lonsdale, Chicago Cubs chairman Tom Ricketts, and Lettuce Entertain You Restaurants CEO R.J. Melman
Company Information
Company
eMed
Location
Miami, Florida, United States
About
eMed is a Miami-based digital healthcare company that uses artificial intelligence to reshape employee wellness and expand healthcare access. The startup offers employee health benefits including access to GLP-1 medications, at-home blood testing, and ongoing clinical support. eMed's empathic agentic AI platform is designed to help employers provide structured care while managing healthcare costs. The company is preparing to launch a new capitated care model to further expand access to healthcare services.
Fundz sees it the moment eMed raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.